Kestra Medical Technologies (KMTS) Stock Overview
Operates as a wearable medical device and digital healthcare company. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
KMTS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Kestra Medical Technologies, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$19.46 |
| 52 Week High | US$30.00 |
| 52 Week Low | US$13.25 |
| Beta | 0 |
| 1 Month Change | -16.41% |
| 3 Month Change | -26.37% |
| 1 Year Change | -16.94% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.90% |
Recent News & Updates
Shareholder Returns
| KMTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.9% | -2.1% | -1.9% |
| 1Y | -16.9% | -12.3% | 14.7% |
Return vs Industry: KMTS underperformed the US Medical Equipment industry which returned -12.3% over the past year.
Return vs Market: KMTS underperformed the US Market which returned 14.7% over the past year.
Price Volatility
| KMTS volatility | |
|---|---|
| KMTS Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: KMTS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: KMTS's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 330 | Brian Webster | kestramedical.com |
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Kestra Medical Technologies, Ltd. Fundamentals Summary
| KMTS fundamental statistics | |
|---|---|
| Market cap | US$1.14b |
| Earnings (TTM) | -US$148.12m |
| Revenue (TTM) | US$83.72m |
Is KMTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KMTS income statement (TTM) | |
|---|---|
| Revenue | US$83.72m |
| Cost of Revenue | US$42.91m |
| Gross Profit | US$40.81m |
| Other Expenses | US$188.94m |
| Earnings | -US$148.12m |
Last Reported Earnings
Jan 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.54 |
| Gross Margin | 48.75% |
| Net Profit Margin | -176.92% |
| Debt/Equity Ratio | 14.7% |
How did KMTS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/29 02:40 |
| End of Day Share Price | 2026/03/27 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2025/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kestra Medical Technologies, Ltd. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Travis Steed | BofA Global Research |
| Marie Thibault | BTIG |